Carpentier-Edwards PERIMOUNT Magna Mitral Ease valve
Built upon the unique and proven PERIMOUNT design, the Magna Mitral Ease valve gives you and your patients:
- Ultra-low profile, with reduced ventricular projection by up to 40%‡
- Exceptional long-term durability1-7
- Ease of implant
The Magna Mitral Ease valve is built upon the proven, time-tested PERIMOUNT valve design, with unique design elements including:
- Mathematically modeled, bioengineered design. Intended to optimize implantability, hemodynamics and long-term durability
- Flexible cobalt-chromium alloy stent. Absorbs energy to reduce leaflet stress
- Three independent bovine pericardial leaflets. Matched for thickness and elasticity to optimize stress distribution
‡ As compared to the Carpentier-Edwards PERIMOUNT Theon mitral valve.
Magna Mitral Ease heart valve
Model 7300TFX Nominal Specifications (mm) | Size 25 | Size 27 | Size 29 | Size 31 | Size 33 |
A. Stent Diameter (Wireform) | 25 | 27 | 29 | 31 | 31 |
B. Tissue Annulus Diameter | 28 | 29.5 | 31.5 | 33.5 | 33.5 |
C. External Sewing Ring Diameter | 36 | 38 | 40 | 42 | 44 |
D. Anterior Effective Profile | 7 | 7.5 | 8 | 8.5 | 8.5 |
* No clinical data are available that evaluate the long-term impact of the Edwards Lifesciences tissue treatments in patients.
References:
- Jamieson WRE, et al. Structural Valve Deterioration in Mitral Replacement Surgery: Comparison of Carpentier-Edwards Supra-Annular Porcine and PERIMOUNT Pericardial Bioprostheses. J Thorac Cardiovasc Surg. 1999 Aug;118:297-305. (Freedom from explant due to structural valve deterioration; n = 429; mean age = 60.7 ± 11.7 yrs)
- Aupart MR, et al. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg. 1997 Mar;113(3):492-8. (Freedom from structural deterioration; n = 150; mean age = 62.9 ± 11.9 yrs)
- Murakami T, et al. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results. J Heart Valve Dis. 1996 Jan;5(1):45-9. (Freedom from structural deterioration; n = 57; mean age = 55.1 ± 13.2 yrs)
- Poirier NC, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:S57-61. (Freedom from structural deterioration; n = 214; mean age = 65 ± 23 yrs)
- Neville PH, et al. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66(6 Suppl):S143-7. (Freedom from structural deterioration; n = 182; mean age = 63.9 ± 11.5 yrs)
- Marchand MA, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001 May;71(5 Suppl):S236-9. (Freedom from structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)
- Bourguignon, T, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25 year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014 Nov;148:2004-11. (Freedom from explant due to structural valve deterioration; n = 404; mean age = 68.0 ± 10.4 yrs)
- Carpentier-Edwards PERIMOUNT pericardial bioprosthesis 16-year results. Data on file at Edwards Lifesciences, 2003. (Freedom from explant due to structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)
Carpentier-Edwards PERIMOUNT Theon valve
Designed specifically for the mitral valve position...
Bioengineered PERIMOUNT design
- Mathematically modeled bioengineered design is intended to optimize implantability, hemodynamics and long-term durability1-7
- Flexible cobalt-chromium alloy stent absorbs energy during the cardiac cycle
- Three independent symmetrical pericardial leaflets matched for thickness and elasticity are mounted under a flexible stent
Mitral design
- Black suture markers indicate proper orientation
Implantability
- The Tricentrix holder system is intended to provide ease of implant
- When fully deployed, the commissures should deflect towards the center of the valve, helping to guide sutures into their correct position and prevent the formation of suture loops
Tissue treatment
- The PERIMOUNT Theon valve is treated with the Carpentier-Edwards ThermaFix process*, confronting both major calcium binding sites: residual glutaraldehydes and phospholipids
* No clinical data are available that evaluate the long-term impact of the Edwards Lifesciences tissue treatments in patients.
The Tricentrix holder system is intended to provide ease of implant
PERIMOUNT Theon mitral valve
Models
Model | Description | Sizes | Image |
6900PTFX | Carpentier-Edwards PERIMOUNT Theon mitral pericardial valve with ThermaFix process* | 25, 27, 29, 31, & 33 mm | ![]() |
Accessories
Model | Description | Compatible with Valve Models | Sizes |
1169HP or 1169P | Sizer - Individual | 6900PTFX | 25, 27, 29, 31, & 33 mm |
TRAY1169HP or TRAY1169 | Accessory Tray | 6900PTFX | N/A |
1111 | Reusable Handle | 6900P, 6900PTFX, 7300TFX | N/A |
1117 | Flexible, Reusable Mitral Handle | 6900PTFX, 7300TFX | N/A |
1126 | Longer, Single Use Handle | 6900P, 6900PTFX, 7300TFX | N/A |
* No clinical data are available that evaluate the long-term impact of the Edwards Lifesciences tissue treatments in patients.
References:
- Aupart MR, et al. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg. 1997 Mar;113(3):492-8. (Freedom from structural deterioration; n = 150; mean age = 62.9 ± 11.9 yrs)
- Bourguignon, T, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25 year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014 Nov;148:2004-11. (Freedom from explant due to structural valve deterioration, n=450; mean age=68.0 ± 10.4 yrs)
- Jamieson WRE, et al. Structural Valve Deterioration in Mitral Replacement Surgery: Comparison of Carpentier-Edwards Supra-Annular Porcine and PERIMOUNT Pericardial Bioprostheses. J Thorac Cardiovasc Surg. 1999 Aug;118:297-305. (Freedom from explant due to structural valve deterioration; n = 429; mean age = 60.7 ± 11.7 yrs)
- Marchand MA, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001 May;71(5 Suppl):S236-9. (Freedom from explant due to structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)
- Murakami T, et al. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results. J Heart Valve Dis. 1996 Jan;5(1):45-9. (Freedom from structural deterioration; n = 57; mean age = 55.1 ± 13.2 yrs)
- Neville PH, et al. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66(6 Suppl):S143-7. (Freedom from structural deterioration; n = 182; mean age = 63.9 ± 11.5 yrs)
- Poirier NC, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:S57-61. (Freedom from structural deterioration; n = 214; mean age = 65 ± 23 yrs)
Carpentier-Edwards PERIMOUNT Plus valve
Designed specifically for the mitral valve position...
Bioengineered PERIMOUNT design
- Mathematically modeled bioengineered design is intended to optimize implantability, hemodynamics and long-term durability1-7
- Flexible cobalt-chromium alloy stent absorbs energy during the cardiac cycle
- Three independent symmetrical pericardial leaflets matched for thickness and elasticity are mounted under a flexible stent
Mitral design
- Black suture markers indicate proper orientation
Implantability
- The Tricentrix holder system is intended to provide ease of implant
- When fully deployed, the commissures should deflect towards the center of the valve, helping to guide sutures into their correct position and prevent the formation of suture loops
Tissue treatment
- The PERIMOUNT Plus valve is treated with the XenoLogiX treatment*, a two-step process targeting residual phospholipids
* No clinical data are available that evaluate the long-term impact of the Edwards Lifesciences tissue treatments in patients.
Model 6900P
PERIMOUNT Plus mitral valve
Models
Model | Description | Sizes | Image |
6900P | Carpentier-Edwards PERIMOUNT Plus mitral pericardial valve | 25, 27, 29, 31, & 33 mm | ![]() |
Accessories
Model | Description | Compatible with Valve Models | Sizes |
1169P | Sizer - Individual | 6900P, 6900PTFX | 25, 27, 29, 31, & 33 mm |
1111 | Reusable Handle | 6900P, 6900PTFX, 7300TFX | N/A |
1126 | Longer, Single Use Handle | 6900P, 6900PTFX, 7300TFX | N/A |
References:
- Aupart MR, et al. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg. 1997 Mar;113(3):492-8. (Freedom from structural deterioration; n = 150; mean age = 62.9 ± 11.9 yrs)
- Bourguignon, T, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25 year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014 Nov;148:2004-11. (Freedom from explant due to structural valve deterioration, n=450; mean age=68.0 ± 10.4 yrs)
- Jamieson WRE, et al. Structural Valve Deterioration in Mitral Replacement Surgery: Comparison of Carpentier-Edwards Supra-Annular Porcine and PERIMOUNT Pericardial Bioprostheses. J Thorac Cardiovasc Surg. 1999 Aug;118:297-305. (Freedom from explant due to structural valve deterioration; n = 429; mean age = 60.7 ± 11.7 yrs)
- Marchand MA, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001 May;71(5 Suppl):S236-9. (Freedom from explant due to structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)
- Murakami T, et al. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results. J Heart Valve Dis. 1996 Jan;5(1):45-9. (Freedom from structural deterioration; n = 57; mean age = 55.1 ± 13.2 yrs)
- Neville PH, et al. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66(6 Suppl):S143-7. (Freedom from structural deterioration; n = 182; mean age = 63.9 ± 11.5 yrs)
- Poirier NC, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:S57-61. (Freedom from structural deterioration; n = 214; mean age = 65 ± 23 yrs)